Edition:
United Kingdom

Marinus Pharmaceuticals Inc (MRNS.OQ)

MRNS.OQ on NASDAQ Stock Exchange Global Market

5.23USD
23 May 2018
Change (% chg)

$0.31 (+6.30%)
Prev Close
$4.92
Open
$4.92
Day's High
$5.25
Day's Low
$4.91
Volume
129,643
Avg. Vol
219,816
52-wk High
$9.86
52-wk Low
$1.13

Chart for

About

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral... (more)

Overall

Beta: 2.63
Market Cap(Mil.): $199.36
Shares Outstanding(Mil.): 40.52
Dividend: --
Yield (%): --

Financials

  MRNS.OQ Industry Sector
P/E (TTM): -- 28.66 32.90
EPS (TTM): -0.70 -- --
ROI: -52.95 13.20 12.74
ROE: -53.77 14.95 14.64

BRIEF-Marinus Pharmaceuticals Provides Business Update And 2017 Financial Results

* MARINUS PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND 2017 FINANCIAL RESULTS

06 Mar 2018

Earnings vs. Estimates